関連する実験動画
Updated: Sep 9, 2025

07:32
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
458
アルツハイマー病における静かな神経保護剤としての脳内の硫化水素
Himanshu Layal1, Jitumani Rajbongshi2, Rohit Kumar1
1Department of Life Sciences and Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur, UP 208024, India.
Neuroscience
|September 4, 2025
まとめ
ガス伝達物質である硫化水素 (H2S) は 脳機能と記憶に不可欠です 低H2Sレベルはアルツハイマー病と関連しており,治療の可能性を示唆しています.
科学分野:
- 神経科学
- 生物化学
- 薬理学について
背景:
- 硫化水素 (H2S) は細胞信号伝達と脳機能に不可欠な内生ガス伝達物質です.
- H2SはNMDA受容体を調節し,記憶の統合と神経伝達に影響を与えます.
- H2Sを合成する主要な酵素は,シスタチオニン γ-ライアス (CSE),シスタチオニン β-シンタゼ (CBS),および3-メルカプトピルバート硫黄転移酶 (MST) です.
研究 の 目的:
- アルツハイマー病 (AD) でのH2Sの統合され,更新された役割をレビューする.
- ADにおけるH2Sの役割における最近のメカニズム的進歩を強調する.
- H2SベースのADの神経療法戦略を統合する新しい視点を提示します.
主な方法:
- H2Sの合成,機能,アルツハイマー病におけるその影響に焦点を当てた文献レビュー.
- アルツハイマー病患者のH2Sレベルに関する既存の研究の分析
- H2Sベースの治療戦略に関する新たな発見の探求
主要な成果:
- H2Sは記憶形成,炎症軽減,血管緩解,血管新生に重要な役割を果たします.
- アルツハイマー病患者は対照群と比較してH2S濃度が著しく低下しています.
- CBS,CSE,MSTは,脳の領域と細胞タイプにおけるH2S生成に差異的に寄与する.
結論:
- H2Sは神経生理学的機能の重要な調節体であり,アルツハイマー病の潜在的な治療標的である.
- ADのH2Sレベルが低下すると,病気状態では保護的な役割が損なわれていることが示唆される.
- H2Sベースの新しい戦略は,アルツハイマー病の治療に新しい治療法を提供します.
関連する概念動画
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Role of Neurotransmitters in Memory
959
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
959
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.4K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.4K

